Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study
Clinical trial NCT05867160 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05867160
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-02
- Primary completion
- 2025-09-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.